专利号:US-6372938-B1 优先权日:2001-05-21 标题:Synthesis of 4-phenylbutyric acid 发明人:BURZYNSKI STANISLAW R; MUSIAL LESZEK 权利人:BURZYNSKI STANISLAW R 摘要:A method of synthesizing compounds of Formula I:by reacting aromatic compounds with butyrolactone, followed by neutralization with base. The reaction can be conducted in the presence of a catalyst. Preferred catalysts are Lewis acids. A preferred product of Formula I is 4-phenylbutyric acid, which is obtained by the reaction of benzene with butyrolactone in the presence of aluminum chloride, followed by neutralization with base.
专利号:US-9995750-B2 优先权日:2013-12-05 标 题:Methods of detecting and measuring glutamine and analogues thereof, and methods related thereto 发明人:ACKERLEY DAVID FRANCIS; BROWN ALISTAIR SINCLAIR; ROBINS KATHERINE JANE 权利人:VICTORIA LINK LTD 摘要:Method for the detection of glutamine and its analogs are provided by the present disclosure. Also provided are methods for measuring the levels of glutamine and its analogs, including diagnostic methods. Further provided are methods that utilize glutamine analogs for the synthesis of colored pigments and other useful agents. The methods comprise the use of a nonribosomal peptide synthetase (NRPS) under conditions to produce an indigoidine or indigoidine-related pigment.
专利号:US-4016147-A 优先权日:1975-01-16 标题:Method for preparation of low-phenylalanine plastein 发明人:FUJIMAKI MASAO; ARAI SOICHI; WATANABE MICHIKO 权利人:FUJI OIL CO LTD 摘要:Method for the preparation of a low-phenylalanine plastein comprising hydrolyzing stepwise a certain albumin or globulin protein with an endopeptidase having an affinity for the aromatic acid components, and an exopeptidase, subjecting the hydrolyzate thus-obtained to gel-filtration to divide it into two fractions, one being constituted with aromatic amino acids and the other being constituted with oligopeptides almost free from the aromatic amino acids, and then subjecting the latter fraction to usual plastein synthesis. Tyrosine and/or tryptophan may be added to the substrate at the plastein synthesis in order to incorporate them into the plastein molecules. The resultant plasteins may be purified through ultra-filtration in order to remove the remaining free amino acids and low-molecular peptides.
专利号:EP-0069232-B1 优先权日:1981-07-02 标题 :Pharmaceutical composition comprising phenyl acetyl glutamine,a combination of this compound with phenylacetic acid or 3-(phenylacetylamino)piperidine-2,6-dione,a process for isolating the latter from urine and a process for the synthesis of 3-(phenylacetylamino)piperidine-2,6-dione
专利号:WO-2024102342-A1 优先权日:2022-11-10 标 题 :Combination of a glutathione synthesis inhibitor such as buthionine sulphoximine and an immune checkpoint inhibitor, preferably pembrolizumab, to treat cancer, preferably drug-resistant melanoma 发明人:SCHULTZ MICHAEL K; KAPOOR SOMYA; SPITZ DOUGLAS R 权利人:UNIV IOWA RES FOUND 摘要:The present invention relates to a process of removing free-unlabeled radionuclides from a radiopharmaceutical prior to administering the radiopharmaceutical to the patient using size-exclusion or ion-exchange mechanisms.
专利号:EP-0069232-A2 优先权日:1981-07-02 标题 :Pharmaceutical composition comprising phenyl acetyl glutamine,a combination of this compound with phenylacetic acid or 3-(phenylacetylamino)piperidine-2,6-dione,a process for isolating the latter from urine and a process for the synthesis of 3-(phenylacetylamino)piperidine-2,6-dione
1: Mair RD, Sirich TL, Meyer TW. Uremic Toxin Clearance and Cardiovascular Toxicities. Toxins (Basel). 2018 Jun 2;10(6). pii: E226. doi: 10.3390/toxins10060226. Review. doi: 10.1016/j.atherosclerosis.2018.04.015. Epub 2018 Apr 17. doi: 10.1093/ajcn/nqx072. doi: 10.1002/lt.25046. Epub 2018 May 13. 8: Khodorova NV, Rutledge DN, Oberli M, Mathiron D, Marcelo P, Benamouzig R, Tomé D, Gaudichon C, Pilard S. Urinary Metabolomics Profiles Associated to Bovine Meat Ingestion in Humans. Mol Nutr Food Res. 2018 Feb 22:e1700834. doi: 10.1002/mnfr.201700834. [Epub ahead of print] Available from http://www.ncbi.nlm.nih.gov/books/NBK476300/ doi: 10.1038/s41598-017-17921-x.
合成参考文献
参考文献:10.1038/srep14843 摘要:Giskeødegård GF, Davies SK, Revell VL, Keun H, Skene DJ. Diurnal rhythms in the human urine metabolome during sleep and total sleep deprivation. Scientific Reports. 2015 Oct 09;5(1):14843. doi: 10.1038/srep14843. 参考文献:10.1007/s00109-015-1354-3 摘要:Sin YY, Baron G, Schulze A, Funk CD. Arginase-1 deficiency. Journal of Molecular Medicine. 2015 Oct 14;93(12):1287–96. doi: 10.1007/s00109-015-1354-3. 参考文献:10.1186/s12859-017-1480-8 摘要:van Reenen M, Westerhuis JA, Reinecke CJ, Venter JH. Metabolomics variable selection and classification in the presence of observations below the detection limit using an extension of ERp. BMC Bioinformatics. 2017 Feb 02;18(1):83. 参考文献:10.1038/s41581-019-0172-1 摘要:Meijers B, Evenepoel P, Anders HJ. Intestinal microbiome and fitness in kidney disease. Nat Rev Nephrol. 2019 Sep;15(9):531–45. doi: 10.1038/s41581-019-0172-1. 参考文献:10.1038/s41467-021-24482-1 摘要:Wu P, Chen D, Ding W, Wu P, Hou H, Bai Y, Zhou Y, Li K, Xiang S, Liu P, Ju J, Guo E, Liu J, Yang B, Fan J, He L, Sun Z, Feng L, Wang J, Wu T, Wang H, Cheng J, Xing H, Meng Y, Li Y, Zhang Y, Luo H, Xie G, Lan X, Tao Y, Li J, Yuan H, Huang K, Sun W, Qian X, Li Z, Huang M, Ding P, Wang H, Qiu J, Wang F, Wang S, Zhu J, Ding X, Chai C, Liang L, Wang X, Luo L, Sun Y, Yang Y, Zhuang Z, Li T, Tian L, Zhang S, Zhu L, Chang A, Chen L, Wu Y, Ma X, Chen F, Ren Y, Xu X, Liu S, Wang J, Yang H, Wang L, Sun C, Ma D, Jin X, Chen G. The trans-omics landscape of COVID-19. Nature Communications. 2021 Jul 27;12(1):4543. doi: 10.1038/s41467-021-24482-1.